Health Economics is the application of economic reasoning to questions about health, healthcare resources, production, consumption, financing, incentives, costs and outcomes. Because healthcare resources are finite while potential health needs are extensive, the field examines how choices can be made under scarcity and how different arrangements affect individuals and populations. It studies both the demand for healthcare and the supply of services, as well as the behaviour of patients, clinicians, providers, insurers and governments.
Health Economics does not assume that health can be reduced to money; rather, it provides frameworks for examining trade-offs between resources used and health or other outcomes achieved. Topics include healthcare expenditure, insurance, pricing, provider incentives, labour markets, investment decisions, economic evaluation and distributional consequences. Economic analysis can help determine whether an intervention produces sufficient additional benefit relative to its additional resource requirements, but efficiency is not identical to fairness. A policy can be efficient according to a particular criterion while distributing benefits or burdens in ways that raise important ethical concerns.
Scarcity is a foundational concept in Health Economics because resources such as money, staff time, clinical capacity, medicines and facilities have alternative uses. Opportunity cost describes the value of the best alternative use of resources forgone when a choice is made. This means that the economic cost of an intervention is not limited to its purchase price. A programme requiring substantial staff time may displace another service even if the programme itself has a low monetary expenditure.
Marginal analysis examines the additional costs and benefits associated with an additional unit of activity. This is particularly relevant when deciding whether expanding a service produces enough additional benefit to justify the resources required. Health Economics also distinguishes between costs and prices: a market price may not equal the full resource cost or social cost of an activity. The concept of scarcity therefore connects individual healthcare decisions with system-level allocation, because every resource committed to one purpose is potentially unavailable for another.
Demand for healthcare differs from ordinary consumer demand because health itself is generally valued for the wellbeing and functioning it enables, while healthcare is one means of producing or protecting health. Individuals may demand healthcare because they perceive a need for treatment, but utilisation is influenced by prices, insurance arrangements, income, information, availability, clinical recommendations and expectations.
Health insurance changes incentives because it can reduce the direct financial cost paid by the patient while transferring costs to insurers or public systems. Risk pooling allows many people to contribute resources so that the financial consequences of illness are shared. Information asymmetry is important because patients usually possess less technical information than healthcare professionals, while providers may influence the services that patients receive. Provider incentives can therefore affect patterns of treatment and resource use. Health Economics examines these relationships without assuming that all choices are perfectly informed or that markets necessarily operate in healthcare as they do for ordinary goods.
Economic evaluation compares alternative uses of resources by relating costs to consequences. Cost-minimisation analysis is appropriate only when relevant outcomes are established to be equivalent, while cost-effectiveness analysis compares costs with outcomes measured in natural health units such as life-years gained or cases prevented. Cost-utility analysis commonly incorporates preference-based health outcomes, while cost-benefit analysis expresses both costs and benefits in monetary terms. A key concept is the incremental comparison between alternatives rather than considering each intervention in isolation.
An intervention that costs more but produces substantially greater health benefit may have a different economic profile from one that is cheaper but less effective. Discounting is commonly applied in analyses involving costs and outcomes occurring at different times because present and future consequences are treated differently within economic models. Sensitivity analysis explores how conclusions change when uncertain assumptions vary. Economic evaluation is therefore not simply “adding up costs”; it requires explicit definitions of alternatives, perspectives, time horizons, outcomes, uncertainty and resource use.
Health Economics also studies how healthcare is financed and organised. Public taxation, social insurance, private insurance, direct payments and mixed arrangements create different relationships between funding, risk and access. Out-of-pocket payments can expose households to financial hardship, particularly when healthcare needs are unpredictable or expensive. Risk pooling can reduce individual exposure but requires rules concerning eligibility, contributions and covered services. Provider payment mechanisms can influence behaviour because reimbursement may be linked to activity, episodes, budgets, capitation or other structures.
Each arrangement creates incentives that may affect service volume, staffing, innovation, prevention and potentially quality. No financing mechanism is neutral: its effects depend on institutional design, regulation, information and provider behaviour. Health Economics therefore considers not only how much a system spends but how resources are raised, how risks are distributed, how incentives operate and what outcomes result.
Health Economics has an important relationship with efficiency and equity. Efficiency concerns achieving the greatest attainable outcome from available resources under a defined objective, whereas equity concerns how benefits, costs or opportunities are distributed. These objectives can conflict. For example, directing resources towards a group with relatively high potential health gains may improve aggregate outcomes but could produce distributional consequences that require explicit consideration.
Economic evaluation can incorporate distributional concerns through equity weights or other approaches, but these involve normative choices rather than purely technical calculations. The economic value of healthcare may also include productivity, unpaid care, quality of life and broader social consequences, depending on the analytical perspective. A narrow payer perspective can produce different results from a societal perspective because costs and benefits falling outside the payer's budget may be excluded. Clearly defining perspective is therefore crucial.
Economic models are useful when direct evidence is incomplete or when interventions have long-term consequences that cannot be observed within a short study. Decision trees, state-transition models and other approaches can project costs and outcomes over time. Models necessarily simplify reality, so their results depend on assumptions about disease progression, treatment effectiveness, adherence, costs and future events. Validation, transparent assumptions and sensitivity analysis are essential. Real-world economic evaluation also faces problems involving price changes, resource valuation, productivity effects, informal care and uncertainty about long-term outcomes. A model should not be mistaken for direct observation of the future. Its value lies in making assumptions explicit and examining their implications systematically.
The development of Health Economics has increasingly connected economic analysis with health technology assessment, healthcare planning, public expenditure and priority-setting. It provides decision-makers with structured information about trade-offs that would otherwise remain implicit. However, economic analysis cannot determine every healthcare decision because values such as dignity, rights, severity of illness, social solidarity and individual autonomy may not be fully represented by conventional efficiency measures. Its most useful role is to clarify the resources consumed, outcomes generated, opportunity costs and distributional consequences associated with competing choices. Health Economics therefore combines quantitative analysis with institutional and ethical reasoning, helping explain why healthcare decisions inevitably involve choices about scarce resources and competing objectives.
